Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Salvianolic acid B ameliorates CNS autoimmunity by suppressing Th1 responses.
Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG34-56 Peptide.
Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Immunology for understanding the pathogenesis of multiple sclerosis.
Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'
Remyelination therapy goes to trial for multiple sclerosis.
Multiparity in women with multiple sclerosis causes less long-term disability: Yes.
Neuropathological Techniques to Investigate Central Nervous System Sections in Multiple Sclerosis.
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
Orofaryngeale slikstoornissen bij neurodegeneratieve aandoeningen.
Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life.
Clinical Neurophysiology in multiple sclerosis - From diagnostic tool to biomarker.
Validation of mood measures for people with multiple sclerosis.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.
Factors Influencing Decision-making and Outcome in the Surgical Management of Trigeminal Neuralgia.
A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain.
Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective.
Acute Bilateral Optic Neuritis in Active Ankylosing Spondylitis.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.
Pages
« first
‹ previous
…
607
608
609
610
611
612
613
614
615
…
next ›
last »